When we talk about the need for greater transparency in the drug supply chain, that term can and should mean a few different things.
Editor's note · Context
Crapo discusses the importance of transparency in the drug supply chain.
Share & report
More from Mike Crapo
Mr. President, once again, I would urge my colleagues to oppose this amendment. Once again, it is a list of dire consequences that are not happening and are not in this legislation. The creation of such a point of order is outside the…
Mr. President, again, my colleagues continue to argue that our now-wealthy companies are showered with an ever-increasing tax break and need to pay their fair share. I would point out that the TCJA that we are talking about in this…
Mr. President, I rise today to urge my colleagues to vote in favor of the confirmation of Mr. Jamieson Greer, who is nominated to serve as the U.S. Trade Representative. I think I ought to just probably set a couple of facts straight about…
Mr. President, once again, I think I have said this 10 times tonight. I will say it again. The budget blueprint we are working on does not deal with Medicare and Medicaid. It is to secure the border, strengthen the military, and facilitate…





